{"id":3184,"date":"2022-08-23T02:15:52","date_gmt":"2022-08-22T17:15:52","guid":{"rendered":"https:\/\/www.wacc.co.jp\/english\/?page_id=3184"},"modified":"2025-12-22T18:04:42","modified_gmt":"2025-12-22T09:04:42","slug":"pharmaceuticals_ingredients","status":"publish","type":"page","link":"https:\/\/www.wacc.co.jp\/english\/pharmaceuticals\/pharmaceuticals_ingredients\/","title":{"rendered":"APIs \/ Intermediates"},"content":{"rendered":"\n
<\/div>
<\/div>
<\/div><\/div>\n\n\n\n

Active Pharmaceutical Ingredients<\/span><\/h3><\/div><\/div>\n\n\n\n

We mainly supply APIs to pharmaceutical manufacturers, including originators, generic drug companies, and OTC (over-the-counter) drug companies. We also coordinate the outsourcing of drug formulation manufacturers by utilizing our various experience and information. Moreover, we focus on sales of our own and BASF's pharmaceutical vitamins, following in the footsteps of Takeda Pharmaceutical Industries, Ltd.<\/p>\n\n\n\n

<\/div>
<\/div>
<\/div><\/div>\n\n\n\n

Ophthalmology<\/span><\/h3><\/div><\/div>\n\n\n
    \n
  • Tetrahydrozoline hydrochloride<\/li>\n
  • Tafluprost<\/li>\n
  • Timolol Maleate<\/li>\n
  • Travoprost<\/li>\n
  • Bimatoprost<\/li>\n
  • Brimonidine tartrate<\/li>\n
  • Bromfenac sodium hydrate<\/li>\n
  • Latanoprost<\/li>\n
  • Isopropyl unoprostone (under development)<\/li>\n
  • Dorzolamide Hydrochloride (under development)<\/li>\n
  • Ripasudil hydrochloride hydrate (under development)<\/li>\n<\/ul>\n\n\n
    <\/div>
    <\/div>
    <\/div><\/div>\n\n\n\n

    Antihypertensive agent<\/span><\/h3><\/div><\/div>\n\n\n
      \n
    • Irbesartan<\/li>\n
    • Telmisartan<\/li>\n<\/ul>\n\n\n
      <\/div>
      <\/div>
      <\/div><\/div>\n\n\n\n

      Anticoagulant<\/span><\/h3><\/div><\/div>\n\n\n
        \n
      • Rivaroxaban (under development)<\/li>\n
      • Edoxaban tosilate hydrate (under development)<\/li>\n
      • Apixaban (under development)<\/li>\n<\/ul>\n\n\n
        <\/div>
        <\/div>
        <\/div><\/div>\n\n\n\n

        Antidiabetic agent<\/span><\/h3><\/div><\/div>\n\n\n
          \n
        • Metformin hydrochloride<\/li>\n
        • Empagliflozin (under development)<\/li>\n
        • dapagliflozin propylene glycolate hydrate (under development)<\/li>\n<\/ul>\n\n\n
          <\/div>
          <\/div>
          <\/div><\/div>\n\n\n\n

          Antipyretic analgesics<\/span><\/h3><\/div><\/div>\n\n\n
            \n
          • Loxoprofen sodium hydrate<\/li>\n<\/ul>\n\n\n
            <\/div>
            <\/div>
            <\/div><\/div>\n\n\n\n

            Anticancer drug<\/span><\/h3><\/div><\/div>\n\n\n
              \n
            • Cabozantinib (under development)<\/li>\n
            • Gemcitabine hydrochloride<\/li>\n<\/ul>\n\n\n
              <\/div>
              <\/div>
              <\/div><\/div>\n\n\n\n

              Antipsychotics<\/span><\/h3><\/div><\/div>\n\n\n
                \n
              • Aripiprazole<\/li>\n
              • Brexpiprazole (under development)<\/li>\n<\/ul>\n\n\n
                <\/div>
                <\/div>
                <\/div><\/div>\n\n\n\n

                Antibiotics<\/span><\/h3><\/div><\/div>\n\n\n
                  \n
                • Tetracycline hydrochloride<\/li>\n
                • Nadifloxacin<\/li>\n<\/ul>\n\n\n
                  <\/div>
                  <\/div>
                  <\/div><\/div>\n\n\n\n

                  Antifungal agent<\/span><\/h3><\/div><\/div>\n\n\n
                    \n
                  • Efinaconazole (under development)<\/li>\n<\/ul>\n\n\n
                    <\/div>
                    <\/div>
                    <\/div><\/div>\n\n\n\n

                    Disinfectant<\/span><\/h3><\/div><\/div>\n\n\n
                      \n
                    • Benzethonium chloride<\/li>\n<\/ul>\n\n\n
                      <\/div>
                      <\/div>
                      <\/div><\/div>\n\n\n\n

                      Prostate enlargement treatment drugs<\/span><\/h3><\/div><\/div>\n\n\n
                        \n
                      • Silodosin<\/li>\n
                      • Tadalafil<\/li>\n<\/ul>\n\n\n
                        <\/div>
                        <\/div>
                        <\/div><\/div>\n\n\n\n

                        Others<\/span><\/h3><\/div><\/div>\n\n\n
                          \n
                        • Finerenone (under development)<\/li>\n
                        • Tadalafil<\/li>\n
                        • Tafamidis (under development)<\/li>\n
                        • Alprostadil<\/li>\n
                        • Tranexamic acid<\/li>\n<\/ul>\n\n\n
                          <\/div>
                          <\/div>
                          <\/div><\/div>\n\n\n\n

                          Vitamins<\/span><\/h3><\/div><\/div>\n\n\n
                            \n
                          • Ascorbic acid<\/li>\n
                          • Thiamine chloride hydrochloride<\/li>\n
                          • Thiamine mononitrate<\/li>\n
                          • Fursulthiamine hydrochloride<\/li>\n
                          • Riboflavin<\/li>\n
                          • Riboflavin butyrate<\/li>\n
                          • Niacinamide<\/li>\n
                          • Calcium pantothenate<\/li>\n
                          • Pyridoxine hydrochloride<\/li>\n
                          • Cyanocobalamin<\/li>\n
                          • Tocopherol acetate<\/li>\n
                          • Tocopherol calcium succinate (under development)<\/li>\n<\/ul>\n\n\n
                            <\/div>
                            <\/div>
                            <\/div><\/div>\n\n\n\n

                            Pharmaceutical intermediates<\/span><\/h3><\/div><\/div>\n\n\n\n

                            Watanabe Chemical has been working with top pharmaceutical companies from the inception of the new drug development stage, proposing and selling intermediates as well as providing intermediates information.
                            With Japanese manufacturers becoming active in establishing overseas manufacturing base these recent years, we are engaged in gathering information on a global level to provide accurate and abundant information on overseas synthetic manufacturers.<\/p>\n\n\n\n

                            <\/div>
                            <\/div>
                            <\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

                            We mainly supply APIs to pharmaceutical manufacturers, including originators, generic drug companies, and OTC (over-the-counter) drug companies. We also coordinate the outsourcing of drug formulation manufacturers by utilizing our various experience and information. Moreover, we focus on sales of our own and BASF's pharmaceutical vitamins, following in the footsteps of Takeda Pharmaceutical Industries, Ltd. Tetrahydrozoline hydrochloride Tafluprost Timolol Maleate Travoprost Bimatoprost Brimonidine tartrate Bromfenac sodium hydrate Latanoprost Isopropyl unoprostone (under development) Dorzolamide Hydrochloride (under development) Ripasudil hydrochloride hydrate (under development) Irbesartan Telmisartan Rivaroxaban (under development) Edoxaban tosilate hydrate (under development) Apixaban (under development) Metformin hydrochloride Empagliflozin (under development) dapagliflozin propylene glycolate hydrate (under development) Loxoprofen sodium hydrate Cabozantinib (under development) […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":9,"menu_order":25,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"vkexunit_cta_each_option":"disable"},"_links":{"self":[{"href":"https:\/\/www.wacc.co.jp\/english\/wp-json\/wp\/v2\/pages\/3184"}],"collection":[{"href":"https:\/\/www.wacc.co.jp\/english\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.wacc.co.jp\/english\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.wacc.co.jp\/english\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wacc.co.jp\/english\/wp-json\/wp\/v2\/comments?post=3184"}],"version-history":[{"count":41,"href":"https:\/\/www.wacc.co.jp\/english\/wp-json\/wp\/v2\/pages\/3184\/revisions"}],"predecessor-version":[{"id":4942,"href":"https:\/\/www.wacc.co.jp\/english\/wp-json\/wp\/v2\/pages\/3184\/revisions\/4942"}],"up":[{"embeddable":true,"href":"https:\/\/www.wacc.co.jp\/english\/wp-json\/wp\/v2\/pages\/9"}],"wp:attachment":[{"href":"https:\/\/www.wacc.co.jp\/english\/wp-json\/wp\/v2\/media?parent=3184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}